The abstract is read at the publisher; the summary is JClub's.
SNP rs11618521 in the KPNA3 promoter is linked to the age at onset of spinocerebellar ataxia type 3 (SCA3) and regulates KPNA3 promoter activity.
- Why it matters: SCA3 pathogenesis depends on nuclear localization of ataxin-3, and KPNA3 is implicated, but how genetic variation and transcriptional control shape onset timing and KPNA3 expression is unclear.
- What they did: The study analyzed rs11618521 as a promoter SNP and tested allele-specific effects mediated by NANOG on KPNA3 promoter activity, expression, and related cellular phenotypes.
- The result: Pharmacological inhibition of NANOG reduced KPNA3 levels and ameliorated aggregate formation, supporting a NANOG–KPNA3 mechanism that may inform targeted therapeutic strategies for SCA3.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.